The purpose of this study is to evaluate the use of "sampling" of smoking cessation medications (nicotine patches and lozenges) among smokers seen in primary care settings. Half of study participants will be provided with samples of medication, to use however they wish; the other half will not be provided with these samples. All smokers will be advised to quit through routine contact with their physician. After the primary care contact, all participants will be contacted by phone for three brief follow-up interviews, which will involve answering questionnaires about their smoking habits.

Inclusion Criteria:

• age >=18
• daily (25+ days within past 30) cigarette smoker of >5 cigs/day
• English speaking
• recruited through primary care sites aligned with study

Exclusion Criteria:

- no FDA contraindications for use of NRT:

1. not pregnant, breastfeeding, or planning to become pregnant
2. no recent (past 3 months) cardiovascular trauma: MI, stroke

Study consists of 3 follow-up phone calls at 1 month, 3 months, and 6 months post-baseline clinic visit. Adverse events are asked systematically of both groups, at all three follow-up calls.

Adverse Events were monitored/assessed without regard to a specific Adverse Event Term.